Consolidated cash flow statement
| Note | Year ended 31 December 2022 |
Year ended 31 December 2021 (restated figures) |
|
|---|---|---|---|
| Cash flows from operating activities | |||
| Profit before tax from continuing and discontinued operations | 54.1 | 133 | 675 |
|
Share in (profit)/loss of joint ventures |
(128) | (32) | |
|
Depreciation and amortization |
54.1 | 2 216 | 2 101 |
|
Impairment losses on non-financial non-current assets |
54.1 | 214 | 1 129 |
|
Write-down of disposable group due to revaluation to fair value |
460 | − | |
|
Impairment losses on loans granted |
14 | (1) | |
|
Exchange differences |
102 | (10) | |
|
Interest and commissions |
591 | 367 | |
|
Other adjustments of profit before tax |
54.1 | 199 | (91) |
|
Change in working capital |
54.1 | (486) | 1 209 |
|
Income tax paid |
54.1 | (540) | (392) |
| Net cash from operating activities | 2 775 | 4 955 | |
| Cash flows from investing activities | |||
|
Purchase of property, plant and equipment and intangible assets |
54.2 | (3 879) | (3 255) |
|
Purchase of financial assets |
(28) | (28) | |
|
Loans granted |
54.2 | (120) | (1) |
|
Loss of control over a subsidiary |
54.2 | (216) | − |
|
Other payments |
(14) | − | |
| Total payments | (4 257) | (3 284) | |
|
Proceeds from sale of property, plant and equipment and intangible assets |
28 | 76 | |
|
Disposal of financial assets |
54.2 | 180 | 53 |
|
Dividends received |
72 | 47 | |
|
Other proceeds |
1 | 5 | |
| Total proceeds | 281 | 181 | |
| Net cash used in investing activities | (3 976) | (3 103) | |
| Cash flows from financing activities | |||
|
Redemption of debt securities |
(170) | (170) | |
|
Repayment of loans and borrowings |
54.3 | (6 067) | (3 466) |
|
Purchase of non-controlling shares |
54.3 | (1 061) | − |
|
Interest paid |
54.3 | (500) | (343) |
|
Repayment of lease liabilities |
(126) | (117) | |
|
Other payments |
(36) | (24) | |
| Total payments | (7 960) | (4 120) | |
|
Proceeds from contracted loans and borrowings |
54.3 | 9 440 | 2 003 |
|
Subsidies received |
38 | 114 | |
| Total proceeds | 9 478 | 2 117 | |
| Net cash from financing activities | 1 518 | (2 003) | |
|
Net increase/(decrease) in cash and cash
equivalents |
317 | (151) | |
|
Net foreign exchange difference |
(24) | (3) | |
| Cash and cash equivalents at the beginning of the period | 38 | 623 | 774 |
| Cash and cash equivalents at the end of the period, of which: | 38 | 940 | 623 |
|
restricted cash |
38 | 322 | 146 |